Japan · Delayed Price · Currency is JPY EnBio Holdings Statistics
Total Valuation
EnBio Holdings has a market cap or net worth of JPY 5.01 billion. The enterprise value is 11.62 billion.
| Market Cap | 5.01B |
| Enterprise Value | 11.62B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
EnBio Holdings has 8.10 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 8.10M |
| Shares Outstanding | 8.10M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 18.78% |
| Owned by Institutions (%) | 2.01% |
| Float | 3.74M |
Valuation Ratios
The trailing PE ratio is 8.62.
| PE Ratio | 8.62 |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.24, with an EV/FCF ratio of -31.83.
| EV / Earnings | 20.03 |
| EV / Sales | 1.12 |
| EV / EBITDA | 9.24 |
| EV / EBIT | 15.87 |
| EV / FCF | -31.83 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.08.
| Current Ratio | 2.06 |
| Quick Ratio | 1.21 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | 8.18 |
| Debt / FCF | -28.19 |
| Interest Coverage | 4.46 |
Financial Efficiency
Return on equity (ROE) is 5.86% and return on invested capital (ROIC) is 2.78%.
| Return on Equity (ROE) | 5.86% |
| Return on Assets (ROA) | 2.12% |
| Return on Invested Capital (ROIC) | 2.78% |
| Return on Capital Employed (ROCE) | 4.20% |
| Revenue Per Employee | 102.89M |
| Profits Per Employee | 5.74M |
| Employee Count | 101 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.38 |
Taxes
In the past 12 months, EnBio Holdings has paid 347.00 million in taxes.
| Income Tax | 347.00M |
| Effective Tax Rate | 38.64% |
Stock Price Statistics
The stock price has increased by +6.36% in the last 52 weeks. The beta is 0.67, so EnBio Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +6.36% |
| 50-Day Moving Average | 603.98 |
| 200-Day Moving Average | 609.91 |
| Relative Strength Index (RSI) | 54.75 |
| Average Volume (20 Days) | 10,865 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EnBio Holdings had revenue of JPY 10.39 billion and earned 580.00 million in profits. Earnings per share was 71.68.
| Revenue | 10.39B |
| Gross Profit | 2.67B |
| Operating Income | 732.00M |
| Pretax Income | 898.00M |
| Net Income | 580.00M |
| EBITDA | 1.26B |
| EBIT | 732.00M |
| Earnings Per Share (EPS) | 71.68 |
Balance Sheet
The company has 3.76 billion in cash and 10.29 billion in debt, with a net cash position of -6.53 billion or -805.96 per share.
| Cash & Cash Equivalents | 3.76B |
| Total Debt | 10.29B |
| Net Cash | -6.53B |
| Net Cash Per Share | -805.96 |
| Equity (Book Value) | 9.49B |
| Book Value Per Share | 1,161.17 |
| Working Capital | 5.13B |
Cash Flow
In the last 12 months, operating cash flow was 961.00 million and capital expenditures -1.33 billion, giving a free cash flow of -365.00 million.
| Operating Cash Flow | 961.00M |
| Capital Expenditures | -1.33B |
| Free Cash Flow | -365.00M |
| FCF Per Share | -45.06 |
Margins
Gross margin is 25.73%, with operating and profit margins of 7.04% and 5.58%.
| Gross Margin | 25.73% |
| Operating Margin | 7.04% |
| Pretax Margin | 8.64% |
| Profit Margin | 5.58% |
| EBITDA Margin | 12.10% |
| EBIT Margin | 7.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 9.00, which amounts to a dividend yield of 1.46%.
| Dividend Per Share | 9.00 |
| Dividend Yield | 1.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 12.59% |
| Buyback Yield | 0.42% |
| Shareholder Yield | 1.88% |
| Earnings Yield | 11.59% |
| FCF Yield | -7.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EnBio Holdings has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 5 |